151 related articles for article (PubMed ID: 37573193)
1. [Impact of immunotherapy on the therapeutic strategy for the management of stage I non-small cell lung cancer: The radiation oncologist's point of view].
Khalifa J
Cancer Radiother; 2023 Sep; 27(6-7):653-658. PubMed ID: 37573193
[TBL] [Abstract][Full Text] [Related]
2. [Stereotactic radiotherapy for operable stage I non-small cell lung cancer].
Martin É; Nicolet C; Boisselier P; Khalifa J; Thureau S
Cancer Radiother; 2023 Sep; 27(6-7):648-652. PubMed ID: 37563012
[TBL] [Abstract][Full Text] [Related]
3. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.
Kann BH; Verma V; Stahl JM; Ross R; Dosoretz AP; Shafman TD; Gross CP; Park HS; Yu JB; Decker RH
Radiother Oncol; 2019 May; 134():44-49. PubMed ID: 31005223
[TBL] [Abstract][Full Text] [Related]
4. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.
Akthar AS; Ferguson MK; Koshy M; Vigneswaran WT; Malik R
Technol Cancer Res Treat; 2017 Feb; 16(1):15-21. PubMed ID: 26792491
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
Paix A; Noel G; Falcoz PE; Levy P
Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
[TBL] [Abstract][Full Text] [Related]
6. Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: Incidence and proposed risk factors.
Wink KCJ; van Baardwijk A; Troost EGC; De Ruysscher D
Cancer Treat Rev; 2017 May; 56():8-15. PubMed ID: 28437679
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Primer for Radiologists.
Febbo JA; Gaddikeri RS; Shah PN
Radiographics; 2018; 38(5):1312-1336. PubMed ID: 30074857
[TBL] [Abstract][Full Text] [Related]
8. Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC).
Lucas JT; Kuremsky JG; Soike M; Hinson WW; Kearns WT; Hampton CJ; Blackstock AW; Urbanic J
Lung Cancer; 2014 Jul; 85(1):59-65. PubMed ID: 24813936
[TBL] [Abstract][Full Text] [Related]
9. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
Schonewolf CA; Heskel M; Doucette A; Singhal S; Frick MA; Xanthopoulos EP; Corradetti MN; Friedberg JS; Pechet TT; Christodouleas JP; Levin W; Berman A; Cengel KA; Verma V; Hahn SM; Kucharczuk JC; Rengan R; Simone CB
Clin Lung Cancer; 2019 Jan; 20(1):e63-e71. PubMed ID: 30337269
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
Chi A; Fang W; Sun Y; Wen S
JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
[TBL] [Abstract][Full Text] [Related]
11. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.
Tandberg DJ; Tong BC; Ackerson BG; Kelsey CR
Cancer; 2018 Feb; 124(4):667-678. PubMed ID: 29266226
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial.
Timmerman RD; Paulus R; Pass HI; Gore EM; Edelman MJ; Galvin J; Straube WL; Nedzi LA; McGarry RC; Robinson CG; Schiff PB; Chang G; Loo BW; Bradley JD; Choy H
JAMA Oncol; 2018 Sep; 4(9):1263-1266. PubMed ID: 29852037
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.
Eriguchi T; Takeda A; Sanuki N; Tsurugai Y; Aoki Y; Oku Y; Hara Y; Akiba T; Shigematsu N
Lung Cancer; 2017 Jul; 109():62-67. PubMed ID: 28577952
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
[TBL] [Abstract][Full Text] [Related]
15. [Stereotactic radiotherapy of stage I non-small cell lung cancer. State of the art in 2019 and recommendations: Stereotaxy as an alternative to surgery?].
Kaiss H; Mornex F
Cancer Radiother; 2019 Oct; 23(6-7):720-731. PubMed ID: 31471255
[TBL] [Abstract][Full Text] [Related]
16. Alternatives to Surgery for Early-Stage Non-Small Cell Lung Cancer: Stereotactic Radiotherapy.
Beaty BT; Weiner AA
Clin Chest Med; 2020 Jun; 41(2):185-195. PubMed ID: 32402355
[TBL] [Abstract][Full Text] [Related]
17. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
Timmerman RD; Fernando HC
Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.
Nieder C; De Ruysscher D; Gaspar LE; Guckenberger M; Mehta MP; Cheung P; Sahgal A
Strahlenther Onkol; 2017 Jul; 193(7):515-524. PubMed ID: 28424839
[TBL] [Abstract][Full Text] [Related]
19. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
20. The role of surgery for stage I non-small cell lung cancer in octogenarians in the era of stereotactic body radiotherapy in the Netherlands.
de Ruiter JC; Heineman DJ; Daniels JM; van Diessen JN; Damhuis RA; Hartemink KJ
Lung Cancer; 2020 Jun; 144():64-70. PubMed ID: 32371262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]